The Cancer Letter

Inside information on cancer research and drug development

Three weeks in Mariupol; How Dr. Hanych kept his cancer patients alive amid Russia’s attack

In Brief

Wistar receives $5M merit extension award from NCI
RTOG Foundation establishes four new committees; names committee leaders
Nine oncology practices certified through ASCO Patient-Centered Cancer Care Certification pilot
Nicholas Shungu named associate director for DEI at MUSC Hollings
Ju Dong Yang named medical director of the Liver Cancer Program Cedars-Sinai Cancer Center
Nithya Cherukuru named assistant professor at Fox Chase

Drugs & Targets

Lynparza approved by the EC as adjuvant treatment for high-risk breast cancer
MD Anderson and TransCode Therapeutics collaborate to advance RNA therapies
Poseida, Roche to collaborate on allogeneic CAR T-cell therapies for hematologic malignancies
FDA accepts ImmunityBio’s BLA for bladder cancer therapy N-803
Merck pays $35M to Kelun-Biotech for rights to investigational antibody drug conjugate
Mission Bio establishes early access program for single-cell measurable residual disease detection in blood cancers

In The Clinic

Trials & Tribulations

All colorectal cancer patients require germline testing at diagnosis and somatic testing at advanced disease diagnosis

All colorectal cancer patients require germline testing at diagnosis and somatic testing at advanced disease diagnosis
Burnout from the elusive quest for quality
Trials & Tribulations
Transforming the future of radiation oncology:
Trials & Tribulations
ANCHOR trial shows that treatment of anal high-grade squamous intraepithelial lesions prevents anal cancer in people with HIV Three ways collaboration accelerates FLASH radiation therapy research
Trials & Tribulations
In early results “unprecedented in rectal cancer,” 14/14 patients show clinical complete response to dostarlimab

Latest Issue

Read the latest issue
DOWNLOAD THE PDF

UPCOMING EVENTS

There are no upcoming events

The Cancer Letter is an independent weekly news publication and the leading source for information on the issues that shape oncology.

Login

Looking for IP Login?